Literature DB >> 1008843

Resistance to hepatic action of vasopressin in genetically obese (ob/ob) mice.

D A Hems, G Y Ma.   

Abstract

1. Fatty acid synthesis, measured in the perfused liver of genetically obese (ob/ob) mice with 3H2O or [14C]actate, did not show the inhibition by [8-arginine]vasopressin (antidiuretic hormone) that is observed in livers from normal mice. 2. Hepatic glycogen breakdown in obese mice was stimuulated by vasopressin, but not as extensively as in lean mice. 3. If obese mice received a restricted amount of food, then fatty acid synthesis still did not respond to vasopressin, but glycogen breakdown was fully stimulated. 4. Cholesterol synthesis was not inhibited by vasopressin in livers from obese mice. 5. Vasopressin inhibited fatty acid synthesis in intact lean mice, but not in obese animals. 6. These results suggest that genetic obesity could be due to an inborn error within the mechanisms (other than adenylate cyclase) which mediate responses to extracellular effectors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008843      PMCID: PMC1164196          DOI: 10.1042/bj1600023

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  The activation of liver glycogen phosphorylase by vasopressin.

Authors:  S Keppens; H de Wulf
Journal:  FEBS Lett       Date:  1975-03-01       Impact factor: 4.124

2.  Insulin receptor deficiency in genetic and acquired obesity.

Authors:  A H Soli; C R Kahn; D M Neville; J Roth
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

3.  Stimulation of glycogenolysis and gluconeogenesis by epinephrine independent of its beta-adrenergic function in perfused rat liver.

Authors:  Y Saitoh; M Ui
Journal:  Biochem Pharmacol       Date:  1976-04-01       Impact factor: 5.858

4.  Fatty acid synthesis in the perfused liver of adrenalectomized rats.

Authors:  C J Kirk; T R Verrinder; D A Hems
Journal:  Biochem J       Date:  1976-06-15       Impact factor: 3.857

Review 5.  The hormonal control of hepatic gluconeogenesis.

Authors:  J H Exton; L E Mallette; L S Jefferson; E H Wong; N Friedmann; T B Miller; C R Park
Journal:  Recent Prog Horm Res       Date:  1970

Review 6.  Regulation of insulin secretion.

Authors:  D A Mayhew; P H Wright; J Ashmore
Journal:  Pharmacol Rev       Date:  1969-09       Impact factor: 25.468

7.  In vivo studies on lipogenesis in obese hyperglycaemic (ob-ob) mice: possible role of hyperinsulinaemia.

Authors:  E G Loten; A Rabinovitch; B Jeanrenaud
Journal:  Diabetologia       Date:  1974-02       Impact factor: 10.122

8.  Lack of correlation between catecholamine effects on cyclic adenosine 3':5'-monophosphate and gluconeogenesis in isolated rat liver cells.

Authors:  M E Tolbert; F R Butcher; J N Fain
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

9.  The control of insulin receptors in the New Zealand obese mouse.

Authors:  D Baxter; N R Lazarus
Journal:  Diabetologia       Date:  1975-08       Impact factor: 10.122

10.  Inhibition of fatty acid synthesis and stimulation of glycogen breakdown by vasopressin in the perfused mouse liver.

Authors:  G Y Ma; D A Hems
Journal:  Biochem J       Date:  1975-11       Impact factor: 3.857

View more
  9 in total

1.  Relationship between lipolysis and calcium in epididymal adipose tissue of obese-hyperglycaemic mice.

Authors:  J P Dehaye; J Winand; P Poloczek; J Christophe
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

2.  The role of insulin in the regulation of stearic acid desaturase activity in liver and adipose tissue from obese--hyperglycaemic (ob/ob) and lean mice.

Authors:  M Enser
Journal:  Biochem J       Date:  1979-06-15       Impact factor: 3.857

3.  Effects of glucagon and insulin on fatty acid synthesis and glycogen degradation in the perfused liver of normal and genetically obese (ob/ob) mice.

Authors:  G Y Ma; C D Gove; D A Hems
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

4.  Opioid peptides and alpha-melanocyte-stimulating hormone in genetically obese (ob/ob) mice during development.

Authors:  J Rossier; J Rogers; T Shibasaki; R Guillemin; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

5.  Effects of torula and brewer's yeast diets in obese and lean mice.

Authors:  B J Stoecker; Y C Li; D B Wester; S B Chan
Journal:  Biol Trace Elem Res       Date:  1987-12       Impact factor: 3.738

6.  Impairment of effects of vasopressin on [1-14C]oleate metabolism in hepatocytes from obese (ob/ob) mice.

Authors:  M W Edwards; M A Cawthorne; D H Williamson
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

7.  An enzymatic defect in the obese (ob/ob) mouse: loss of thyroid-induced sodium- and potassium-dependent adenosinetriphosphatase.

Authors:  D A York; G A Bray; Y Yukimura
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

8.  Enhanced expressions of arginine vasopressin (Avp) in the hypothalamic paraventricular and supraoptic nuclei of type 2 diabetic rats.

Authors:  Sun Shin Yi; In Koo Hwang; Yo Na Kim; Il Yong Kim; Son-Il Pak; In Se Lee; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

9.  Lack of vasopressin receptors in liver, but not in kidney, of ob/ob mice.

Authors:  F Assimacopoulos-Jeannet; B Cantau; G van de Werve; S Jard; B Jeanrenaud
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.